Atara Biotherapeutics Inc (ATRA)
0.566
-0.04
(-6.24%)
USD |
NASDAQ |
May 08, 16:00
0.566
0.00 (0.00%)
After-Hours: 19:00
Atara Biotherapeutics Cash from Operations (Quarterly): -50.41M for Dec. 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -50.41M |
| September 30, 2023 | -51.35M |
| June 30, 2023 | -52.80M |
| March 31, 2023 | -38.43M |
| December 31, 2022 | -56.88M |
| September 30, 2022 | -65.06M |
| June 30, 2022 | -63.96M |
| March 31, 2022 | -84.53M |
| December 31, 2021 | -34.27M |
| September 30, 2021 | -58.98M |
| June 30, 2021 | -61.58M |
| March 31, 2021 | -65.70M |
| December 31, 2020 | -4.12M |
| September 30, 2020 | -52.96M |
| June 30, 2020 | -56.64M |
| March 31, 2020 | -67.04M |
| December 31, 2019 | -58.69M |
| September 30, 2019 | -52.15M |
| June 30, 2019 | -54.59M |
| March 31, 2019 | -70.20M |
| December 31, 2018 | -57.42M |
| September 30, 2018 | -48.10M |
| Date | Value |
|---|---|
| June 30, 2018 | -39.43M |
| March 31, 2018 | -34.82M |
| December 31, 2017 | -24.94M |
| September 30, 2017 | -20.23M |
| June 30, 2017 | -20.30M |
| March 31, 2017 | -22.03M |
| December 31, 2016 | -21.16M |
| September 30, 2016 | -15.58M |
| June 30, 2016 | -10.79M |
| March 31, 2016 | -12.49M |
| December 31, 2015 | -11.39M |
| September 30, 2015 | -12.90M |
| June 30, 2015 | -6.242M |
| March 31, 2015 | -6.622M |
| December 31, 2014 | -4.957M |
| September 30, 2014 | -4.092M |
| June 30, 2014 | -4.662M |
| March 31, 2014 | -2.917M |
| December 31, 2013 | -2.489M |
| September 30, 2013 | -1.689M |
| June 30, 2013 | 1.129M |
| March 31, 2013 | -2.917M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-84.53M
Minimum
Mar 2022
-4.12M
Maximum
Dec 2020
-54.22M
Average
-56.64M
Median
Jun 2020
Cash from Operations (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | -0.314M |
| Palatin Technologies Inc | -10.48M |
| iBio Inc | -4.706M |
| Theriva Biologics Inc | -6.541M |
| Oragenics Inc | -1.102M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 9.944M |
| Cash from Financing (Quarterly) | 1.512M |
| Free Cash Flow | -194.20M |
| Free Cash Flow Per Share (Quarterly) | -0.4664 |
| Free Cash Flow to Equity (Quarterly) | -50.45M |
| Free Cash Flow to Firm (Quarterly) | -49.98M |
| Free Cash Flow Yield | -324.0% |